Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02986958 · ClinicalTrials.gov registry record · NA
Involving Family to Improve Communication in Primary Care
A NA study of Cognitive Impairment, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
- 3
- Study locations
NCT02986958: Completed NA study of Cognitive Impairment, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT02986958 is a NA study of Cognitive Impairment that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 93 participants, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (86% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02986958, a NA study of Cognitive Impairment, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study evaluates an agenda-setting checklist for patients with cognitive impairment and their family companions that is completed in the waiting room in advance of a primary care visit. The study team will conduct a two-group randomized trial to examine feasibility of the protocol and to compare medical communication (from visit audiotapes) during visits of patient-companion dyads who complete the checklist (n=50) with patient-companion dyads who receive usual care (n=50)
Primary Outcome
Patient-centered communication is reflected as a ratio of psychosocial and socio-emotional statements relative to biomedical talk and orientation statements from coded audio-taped communication during primary care visits. Higher values indicate more patient-centered communication.
Conditions Studied
Interventions
- OTHER Usual care
- OTHER Pre-visit patient-family agenda-setting checklist
Study Locations (3)
Maryland
- Johns Hopkins Community Physicians - Aberdeen
- Medstar Center for Successful Aging - Baltimore
- Johns Hopkins Community Physicians - Westminster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-08 |
| Phase | NA |
What the finished NCT02986958 record still lists
NCT02986958 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT02986958 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT02986958 about?
NCT02986958 is a clinical study titled "Involving Family to Improve Communication in Primary Care". This study evaluates an agenda-setting checklist for patients with cognitive impairment and their family companions that is completed in the waiting room in advance of a primary care visit. The study team will conduct a two-group randomized trial to examine feasibility of the protocol and to compare...
What is the current status of trial NCT02986958?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2016-08. Estimated completion is 2017-08.
What conditions does trial NCT02986958 study?
This clinical trial studies the following conditions: Cognitive Impairment.
What interventions are being tested in trial NCT02986958?
The interventions under investigation include: Usual care (OTHER), Pre-visit patient-family agenda-setting checklist (OTHER).
Who is sponsoring clinical trial NCT02986958?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02986958 being conducted?
This trial has 3 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02986958's enrollment target sits among peer trials
93 47th of 105 higher than 59 of 105 other Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia